News

Bausch Health Announces Adoption of Shareholder Rights Plan
LAVAL, QC / ACCESS Newswire / April 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch ...
Bausch + Lomb recalls lenses used in cataract surgery due to inflammatory reactions
Bausch + Lomb issued the recall after the company received reports of toxic anterior segment syndrome, or an inflammatory ...
Bausch + Lomb recalls several intraocular contact lens systems
Bausch + Lomb, a leading global eye health company, announced a voluntary recall of its Envista Aspire, Envista Envy and ...
Bausch Health: Repositioning Aplezin As First Oral Monotherapy For TRD A $3 Billion Opportunity
Bausch Health's Aplenzin could revolutionize TRD care, addressing a $3B market opportunity while aiding BHC stock's financial ...
Bausch + Lomb announces lenses recall: Here’s what to know
The eye health company Bausch + Lomb announced on Monday that it is recalling several of its intraocular lenses due to safety ...
Bausch + Lomb recalls some of its implantable eye lenses
(Reuters) -Bausch + Lomb said on Thursday it will recall some of its implantable eye lenses after receiving reports of complications, the cause of which could not immediately be known. The company ...
Bausch + Lomb Stock Sinks on 'Voluntary Recall' of Some Implantable Eye Lenses
Bausch + Lomb shares tumbled in intraday trading Friday, a day after the eye-care company announced a "voluntary recall" of ...
Bausch + Lomb (BLCO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
NEW YORK CITY, NY / ACCESS Newswire / April 11, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...
ConsumerAffairs8d
Bausch + Lomb recalls some enVista intraocular lenses
Bausch + Lomb is recalling intraocular lenses (IOLs) on its enVista platform. This action was taken after the company ...
Bausch & Lomb recalls implantable eye lenses due to risk of syndrome that can lead to vision loss
Most cases of TASS can be treated with steroids within a few days, although severe cases can lead to permanent damage to the cornea, the clear, outermost layer of the eye. Severe cases can also lead ...
MPR5d
Bausch + Lomb Issues Recall of enVista Lenses Used in Cataract Surgery
HealthDay News — Bausch + Lomb has announced a voluntary recall of intraocular lenses on its enVista platform due to the potential for an acute postoperative inflammatory reaction.